BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Policy

  Gilead Receives Approval in Canada for YESCARTA™ (Axicabtagene Ciloleucel) CAR T Therapy for Adults With Relapsed or Refractory Large B-cell Lymphoma After Two or More Lines of Systemic Therapy

  YESCARTA is a chimeric antigen receptor T (CAR T) cell therapy that is custom-made for each patient from his or her own T cells.

  February 19, 2019

   · 

  14 min read
• BioForest

  Five Myths and Facts About Cancer Prevention

  The American Institute for Cancer Research (AICR) is leading a national campaign to help Americans separate the myths from facts about cancer risk.

  February 19, 2019

   · 

  3 min read
• Pharm Country

  Researchers suggest balanced reporting of sports head injuries

  A group of more than 60 leading international neuroscientists published a correspondence last week in The Lancet Neurology, asking for balance when reporting on sports-related injury chronic traumatic encephalopathy.

  February 19, 2019

   · 

  2 min read
• Business

  Vapor Group, Inc. (VPOR) Changes Control, New Management to be Appointed to Execute New Business Plan

  Vapor Group, Inc., announced that it had completed and signed the documentation to consummate a change of control of the Company per the “Letter of Intent” (“LOI”) announced previously.

  February 19, 2019

   · 

  2 min read
• Business

  Blueprint Medicines to Report Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019

  Blueprint Medicines Corporation announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, February 26, 2019 to report its fourth quarter and full year 2018 financial results and provide a corporate update.

  February 19, 2019

   · 

  1 min read
• Business

  MercyOne Standardizes Clinical Communication with PerfectServe at Eight Critical Access Hospitals

  MercyOne, a large healthcare system in Iowa, partnered with PerfectServe® to implement its secure communication technology across eight critical access hospitals.

  February 19, 2019

   · 

  2 min read
• Business

  Nobel Prize Winner Professor Aaron Ciechanover appointed senior member on the advisory committee of Panaxia Pharmaceutical

  Dr. Dadi Segal, CEO and founder of Panaxia: “The entrance of a world-renowned scientist places Panaxia Pharmaceutical as a leading contender in the industry, and acts as a vote of confidence in the company’s capabilities.”

  February 19, 2019

   · 

  2 min read
• Deals

  Incyte to Present at Upcoming Investor Conferences - February 19, 2019

  Incyte Corporation announced that it will present at the following investor conferences during the month of March:

  February 19, 2019

   · 

  1 min read
• BioMidwest

  AtriCure Announces The Society of Thoracic Surgeons Has Endorsed the Company’s Advanced Ablation Courses in the United States

  Endorsement complements the company’s ongoing commitment to physician education

  February 19, 2019

   · 

  2 min read
• Business

  4D Molecular Therapeutics Expands Leadership Team with Appointments and Promotions of Key Executives

  4D Molecular Therapeutics, a world-leader in Therapeutic Vector Evolution for adeno-associated virus gene therapy vector discovery and product development, announced the appointments of Fred Kamal, PhD, as chief technical officer, and August Moretti as chief financial officer.

  February 19, 2019

   · 

  5 min read